TLR4 and peritonitis: To understand the roles of TLR9 in these FRC subsets during peritonitis, we challenged the mice with ODN (a TLR9 agonist, 2.5 nmol/mouse, i.p.), LPS (a TLR4 agonist, 5mg/kg, i.p.), and CLP for 18 hours.